Drugmakers to face drug price cuts

Published: 2010-02-24 06:59:00

Updated: 2010-02-24 06:59:00

Domestic and foreign manufacturers of antihypertensive agents is set to face an imminent drug pricing reform with price cut proposals already put forward to the presidential Blue House by the Ministry for Health, Welfare and Family Affairs.

So far, the details of the reform proposal have not b...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK